Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) EBT Margin (2019 - 2025)

Revolution Medicines (RVMD) has 6 years of EBT Margin data on record, last reported at 2670.69% in Q3 2025.

  • For Q3 2025, EBT Margin changed N/A year-over-year to 2670.69%; the TTM value through Dec 2025 reached 9899.38%, changed N/A, while the annual FY2023 figure was 3805.55%, 310141.0% down from the prior year.
  • EBT Margin reached 2670.69% in Q3 2025 per RVMD's latest filing, up from 21831.0% in the prior quarter.
  • Across five years, EBT Margin topped out at 2670.69% in Q3 2025 and bottomed at 21831.0% in Q4 2023.
  • Average EBT Margin over 4 years is 2744.9%, with a median of 716.15% recorded in 2022.
  • Peak YoY movement for EBT Margin: soared 261449bps in 2022, then plummeted -2146159bps in 2023.
  • A 4-year view of EBT Margin shows it stood at 556.83% in 2021, then skyrocketed by 34bps to 369.41% in 2022, then plummeted by -5810bps to 21831.0% in 2023, then soared by 112bps to 2670.69% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 2670.69% in Q3 2025, 21831.0% in Q4 2023, and 2570.55% in Q2 2023.